Ophthalmology Research

Ophthalmology Research

Open Access
ISSN: 2639-9482
Case Report

A Novel Variant in CRB1 Associated with Paravenous Chorioretinal Atrophy and Dyschromatopsia

Authors: Ariza-Torrado Irina P, Martínez-Córdoba Claudia J, Hosse-Ovando Valeria, Groman-Lupa Sergio, Valdes-Barrena Adriana.

DOI: 10.33425/2639-9482.1045


Abstract

Purpose: To report a novel pathological variant of CRB1 previously reported in pigmented paravenous chorioretinal atrophy (PPCRA), present in an infant with color-vision abnormalities.

Case Report: A 6-year-old male is brought for consultation by his parents for noticing color vision deficiency. Visual acuity was 20/30 (LogMAR 0.2) and 20/20 (LogMAR 0.0) in the right and left eye, respectively. Ophthalmologic examination was unremarkable, and optical coherence tomography and retinography were normal. Farnsworth Munsell test was initially normal but follow-up test at 6-months was altered in protanope, deuteranomal and tritanope. Genetic testing revealed a pathogenic variant in CRB1: c.2506 A (p.Pro836Thr).

Conclusion: CRB1 mutations have been associated with a spectrum of ocular diseases, including retinitis pigmentosa, Leber’s congenital amaurosis, and early-onset angle-closure glaucoma. A pathogenic variant associated with PPCRA was found, a rare disorder with no-specific treatment. Most PPCRA patients maintain a stable vision, though the case here presented was associated with dyschromatopsia.

View / Download PDF
Citation: Ariza-Torrado Irina P, Martínez-Córdoba Claudia J, Hosse-Ovando Valeria, et al. A Novel Variant in CRB1 Associated with Paravenous Chorioretinal Atrophy and Dyschromatopsia. 2025; 8(2). DOI: 10.33425/2639-9482.1045
Editor-in-Chief
Fuxiang Zhang
Fuxiang Zhang
Department of Ophthalmology | Downriver Optimeyes Supervision Center-Taylor

View full editorial board →
Journal Metrics
Impact Factor 2.3*
Acceptance Rate 75%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days